The objectives of this Clinical Expert Series on endometrial hyperplasia are to review the
etiology and risk factors, histologic classification and subtypes, malignant progression risks …

Endometrial cancer (EC) is the fourth most common cancer in women in developed
countries. Although it is usually diagnosed in postmenopausal women, its incidence has …

Objective Our objectives were to (1) compare different regimens of hormonal therapy (HT) in
young women with atypical endometrial hyperplasia (AEH) and early endometrial cancer …

Cancer cells are usually featured by metabolic adaptations that facilitate their growth,
invasion, and metastasis. Thus, reprogramming of intracellular energy metabolism is …

Objective To investigate the adjuvant efficacy of metformin treatment to achieve pathological
complete response (CR) in patients with endometrial complex hyperplasia (CH) and …

Total hysterectomy and bilateral adnexectomy is the standard treatment for atypical
endometrial hyperplasia and early-stage endometrial cancer. However, the recommended …

Endometrial cancer (EC) is currently the most common malignancy of the female genital tract
in developed countries. Although it is more common in postmenopausal women, it may …

Simple Summary Endometrial cancer is a common gynecological malignant disease. Its
incidence in women of reproductive age in developed countries is increasing. The standard …

Background We conducted a systematic review and meta-analysis to examine outcomes of
patients with endometrial intraepithelial neoplasia treated with oral progestins or a …

Purpose To assess metformin's effectiveness in adding it to progestin-based hormone
therapy for treating atypical endometrial hyperplasia (AEH) and early endometrial cancer …